No Detail Found!

Clinical Spectrum and Endoscopic Treatment of Gastrointestinal Carcinoid Tumour

Author(s)
Linyun Xue Department of Gastrointestinal Surgery, The First Hospital of Putian Teaching Hospital, Fujian Medical University, Putian, Fujian, China
Yaowu Cai Department of Gastrointestinal Surgery, The First Hospital of Putian Teaching Hospital, Fujian Medical University, Putian, Fujian, China
Wei Chen Department of Gastrointestinal Surgery, The First Hospital of Putian Teaching Hospital, Fujian Medical University, Putian, Fujian, China
Sijie Chen Department of Gastrointestinal Surgery, The First Hospital of Putian Teaching Hospital, Fujian Medical University, Putian, Fujian, China
Pengxing Xue Department of Gastrointestinal Surgery, The First Hospital of Putian Teaching Hospital, Fujian Medical University, Putian, Fujian, China
Abstract
Objective: To analyse the clinical spectrum and endoscopic treatment outcome of patients diagnosed with gastrointestinal carcinoid tumours. Study Design: Case series. Place and Duration of Study: The First Hospital of Putian City of Fujian Province, China from 2012 to 2019. Methodology: Patients with gastrointestinal carcinoid tumours were searched on the gastrointestinal endoscopic database and the hospital medical records database. Patients who were evaluated and treated at other institutions or with insu cient clinical information were excluded. Data were extracted from the databases, including clinical presentation, tumour size and location, treatment, complications of treatment, and clinical and endoscopic follow-up. Results: In 113 cases, 92 tumours were smaller than 1 cm, 16 tumours were between 1-2 cm, and 5 tumours were larger than 2 cm in size. Ninety- ve (84.1%) tumours showed as nodules with smooth surface, and 4(3.5%) as neoplasms with malignant performance. The tumours were limited to the mucosa in 14 (12.4%) cases, invaded into the submucosa in 88 (77.9%) cases, and the muscularis propria in 6 cases (5.3%). Most of the tumours (87.6%) were located in the rectum. The Ki-67 index was more than 30% in cases with metastases. One hundred and eight (95.6%) gastrointestinal carcinoid tumour patients were treated with endoscopic resection including endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD), and 5 (4.4%) patients underwent surgical resection. All 108 patients including the 6 patients with positive margins had no relapse of carcinoid tumour on follow-up. Conclusion: The rectum may be the most common location of gastrointestinal carcinoid tumours in Asian people. Most small tumours located in the stomach, colon, and rectum are nonfunctional, especially in rectum. Endoscopic excision including EMR and ESD is e ective and safe for the treatment of small-sized gastrointestinal carcinoid tumours. Ki-67 index can be a good predictor for malignant potency of gastrointestinal carcinoid tumours.
Publication Details
Page(s) 1330-1333
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 32, Issue: 10, Year: 2022

Request the full text from PASTIC

Keywords
Clinical features, Neuroendocrine tumour, Gastrointestinal carcinoid tumours, Endoscopic treatment
0

Citations

0

Downloads

66

Views